KoBioLabs

KoBioLabs EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of KoBioLabs (348150.KQ) as of Nov 16, 2026 is -11.55. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -10.36 — a change of 11.52% (lower).

EV/EBITDA

-11.55

YoY

11.52%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of KoBioLabs is 2025 -11.55 . EV/EBITDA (Enterprise Value to EBITDA) of KoBioLabs was 2024 -10.36 . It decreases by 11.52% lower compared to the previous year.

The KoBioLabs EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
-42.56 KRW
Jan 1, 2019
-9.91 KRW
Jan 1, 2020
-4.43 KRW
Jan 1, 2021
-1.61 KRW
Jan 1, 2022
-1.20 KRW
Jan 1, 2023
-2.68 KRW
Jan 1, 2024
-10.36 KRW
Jan 1, 2025
-11.55 KRW
The KoBioLabs EV/EBITDA history
YEAREV/EBITDAYoY
-11.55+11.52%
-10.36+286.87%
-2.68+122.35%
-1.20-25.02%
-1.61-63.73%
-4.43-55.31%
-9.91-76.72%
-42.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

EV/EBITDA (Enterprise Value to EBITDA) of KoBioLabs is -11.55 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of KoBioLabs changed from -10.36 to -11.55, representing a 11.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s KoBioLabs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — KoBioLabs

All Key Metrics — KoBioLabs